Luzia Müller

Luzia Müller

Auto-generated profile, based on publicly available information

Luzia Müller

Department of Ophthalmology, Cantonal Hospital of Lucerne, CH-6000 Lucerne-16, Switzerland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Cornea
Verified
Journal Article
Closed access
LMLuzia Müller
Luzia Müller
CKClaude Kaufmann
Claude Kaufmann
LBLucas M. Bachmann
Lucas M. Bachmann
JTJanine N. Tarantino-Scherrer
Janine N. Tarantino-Scherrer
MTMichael A. Thiel
Michael A. Thiel
FBFrank Bochmann
Frank Bochmann
Purpose: To analyze the occurrence of postoperative intraocular pressure (IOP) elevation and types of pressure-lowering treatment in patients after Descemet stripping automated endothelial keratoplasty (DSAEK) with and without previous diagnoses of glaucoma and/or pseudoexfoliation (PXF) syndrome. Methods: This retrospective assessment considered 211 consecutive DSAEK cases (176 patients) performed by 1 surgeon between January 2007 and November 2010 with at least 1-year follow-up. Salient patient characteristics, IOP, and type of antiglaucoma treatment registered in postoperative visits up to 36 months were extracted from medical records. IOP elevation and its association with glaucoma, PXF, and combination of the 2 were assessed using multivariate ordinal logit models. Results: Of 211 eyes, 97 eyes (45%) showed at least 1 increase in IOP >25 mm Hg after DSAEK. Of these 97 eyes, 17 eyes (17.5%) had a history of glaucoma alone, another 17 eyes (17.5%) had a history of glaucoma combined with PXF, 10 eyes (9.7%) had PXF alone, and 53 eyes (54.6%) were steroid responders only. To control IOP elevation, steroid reduction alone was performed in 6 eyes (6.2%) and IOP-lowering medication as the only measure was performed in 26 eyes (26.8%). In 46 eyes (47.4%), steroids were reduced in combination with IOP-lowering medication and 16 eyes (16.5%) required surgery. In 3 eyes (3.1%), no action was required. Presence of PXF (odds ratio, 1.71; 95% confidence interval, 0.62–2.81; P = 0.002) and PXF glaucoma (1.14; 95% confidence interval, 0.06–2.21; P = 0.038) required a more intensive IOP-lowering management than patients without PXF with IOP problems. Conclusions: Increased IOP is common after DSAEK, and a significant number of patients need IOP-lowering treatment. PXF syndrome and PXF glaucoma are risk factors for significant IOP elevation after DSAEK. In most cases, IOP remains controlled with conservative management, but some patients require glaucoma surgery.

16 September 2019 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
LMLuzia Müller
Luzia Müller
BJBerit P. Jensen
Berit P. Jensen
LBLucas M. Bachmann
Lucas M. Bachmann
DWDickson Wong
Dickson Wong
AWAnthony P. Wells
Anthony P. Wells

18 August 2021 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
OPOliver A. Pfaeffli
Oliver A. Pfaeffli
AWAdrian Weber
Adrian Weber
KHKenneth Joseph Hoffer
Kenneth Joseph Hoffer
GSGiacomo Savini
Giacomo Savini
PBPhilipp B. Baenninger
Philipp B. Baenninger
LMLuzia Müller
Luzia Müller
Purpose: To assess agreement of measurements by 2 swept-source optical coherence tomography biometers and to evaluate the prediction error (PE) in intraocular lens power calculation with 7 formulas. Setting: Tertiary public eye hospital. Design: Consecutive observational. Methods: Axial length (AL), keratometry (K), anterior chamber depth (ACD), lens thickness (LT), and corneal diameter (CD) were measured with the IOLMaster 700 (Biometer A) and Anterion (Biometer B). Agreement was quantified by the limits of agreement and concordance correlation coefficient (CCC). The PE, the median absolute error, and the mean absolute error of the Barrett Universal II, EVO 2.0, Haigis, Hoffer Q, Holladay 1, Kane, and SRK/T formulas were investigated after constant optimization. Results: In 78 eyes from 78 patients, excellent agreement was obtained for AL (CCC >0.99), very good agreement for K, ACD, and LT (CCC >0.95), and strong agreement for CD (CCC >0.72). An additive offset of 0.07 mm was measured for ACD and LT whose mean values were higher with Biometer B (P < .001). No statistically significant difference was found between the PEs and their absolute values when comparing the results of each formula between the 2 biometers. Conclusions: Agreement of biometric measurements by the 2 biometers was high, although Biometer B provided higher mean values of ACD and LT by 0.07 mm. In cataract patients with normal eye length, measurements by the 2 biometers did not lead to different refractive outcomes with the 7 formulas investigated.

16 May 2016 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
LMLuzia Müller
Luzia Müller
GRGraham Matthew Balfour Reeves
Graham Matthew Balfour Reeves
JLJames Chiung Yoong Leong
James Chiung Yoong Leong
AWAnthony Philipp Wells
Anthony Philipp Wells

19 July 2023 in Journal of Glaucoma
Verified
Journal Article
Closed access
RFRaphael Fritsche
Raphael Fritsche
LMLuzia Müller
Luzia Müller
FBFrank Md Bochmann
Frank Md Bochmann
An abstract is unavailable. This article is available as a PDF only.